| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. | Chief Technology Officer | Common Stock | 0 | $0 | $54.09 | 09 Dec 2025 | Direct |
| Akero Therapeutics, Inc. | Chief Technology Officer | Stock Option (Right to Buy) | 0 | 09 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 09 Dec 2025 | 5 | $0 | 4 | Chief Technology Officer | 09 Dec 2025, 10:11 |
| AKRO | Akero Therapeutics, Inc. | 15 Aug 2025 | 2 | +$51,012 | 4 | Chief Technology Officer | 19 Aug 2025, 21:32 |
| AKRO | Akero Therapeutics, Inc. | 30 Jun 2025 | 1 | +$7,137 | 4 | Chief Technology Officer | 02 Jul 2025, 18:00 |
| AKRO | Akero Therapeutics, Inc. | 18 Jun 2025 | 1 | -$46,504 | 4 | Chief Technology Officer | 20 Jun 2025, 21:08 |
| AKRO | Akero Therapeutics, Inc. | 16 Dec 2024 | 2 | $0 | 4 | Chief Technology Officer | 18 Dec 2024, 20:56 |
| AKRO | Akero Therapeutics, Inc. | 29 Apr 2024 | 1 | $0 | 4 | Chief Technology Officer | 01 May 2024, 19:36 |
| AKRO | Akero Therapeutics, Inc. | 29 Apr 2024 | 0 | $0 | 3 | Chief Technology Officer | 01 May 2024, 19:32 |